pirfenidone has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, C; Marcus, GM; Nguyen, DT; Olgin, JE; Wilson, E | 1 |
1 other study(ies) available for pirfenidone and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Pirfenidone mitigates left ventricular fibrosis and dysfunction after myocardial infarction and reduces arrhythmias.
Topics: Animals; Echocardiography; Electrophysiologic Techniques, Cardiac; Fibrosis; Heart Conduction System; Heart Ventricles; Male; Myocardial Infarction; Neural Conduction; Pyridones; Rats; Rats, Sprague-Dawley; Tachycardia, Ventricular; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Ventricular Function, Left; Ventricular Remodeling; Voltage-Sensitive Dye Imaging | 2010 |